Enhancement of glucose-induced insulin secretion in transgenic mice overexpressing human VIP gene in pancreatic β cells

Annals of the New York Academy of Sciences

Volumn 805, Issue , 1996, Pages 232-243

  Kato, Ichiro ^a   Suzuki, Yu ^a   Akabane, Atsuya ^a   Yonekura, Hideto ^a   Tanaka, Osamu ^b   Kondo, Hisatake ^a   Takasawa, Shin ^a   Yoshimoto, Takashi ^a   Okamoto, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PEPTIDE HISTIDINE METHIONINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GLUCOSE BLOOD LEVEL; INSULIN RELEASE; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PROMOTER REGION; TRANSGENE;

EID: 0030464705     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17486.x     Document Type: Conference Paper

References (28)

1. SAID, S. I. & V. MUTT. 1972. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem. 28: 199-204.
2. SAID, S. I. 1986. Vasoactive intestinal peptide. J. Endocrinol. Invest. 9: 191-200.
3. ITOH, N., K. OBATA, N. YANAIHARA & H. OKAMOTO. 1983. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 304: 547-549.
4. TAJLMA, M., T. IIDA, S. YOSHIDA, K. KOMATSU, R. NAMBA, M. YANAGI, M. NOGUCHI & H. OKAMOTO. 1990. The reaction product of peptidylglycine α-amidating enzyme is a hydroxyl derivative at α-carbon of the carboxyl-terminal glycine. J. Biol. Chem. 265: 9602-9605.
5. KATO, I., H. YONEKURA, M. TAJIMA, M. YANAGI, H. YAMAMOTO & H. OKAMOTO. 1990. Two enzymes concerned in peptide hormone α-amidation are synthesized from a single mRNA. Biochem. Biophys. Res. Commun. 172: 197-203.
6. NOGUCHI, M., H. SEIKO, H. KOCHI, H. OKAMOTO, T. TANAKA & M. HIRAMA. 1992. The source of the oxygen atom in the α-hydroxyglycine intermediate of the peptidylglycine α-amidating reaction. Biochem. J. 283: 883-888.
7. YAMAGAMI, T., K. OHSAWA, M. NISHIZAWA, C. INDUE, E. GOTOH, N. YANAIHARA, H. YAMAMOTO & H. OKAMOTO. 1988. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Ann. N.Y. Acad. Sci. 527: 87-102.
8. GOTOH, E., T. YAMAGAMI, H. YAMAMOTO & H. OKAMOTO. 1988. Chromosomal assignment of human VIP/PHM-27 gene to 6q26→q27 region by spot blot hybridization and in situ hybridization. Biochem. Int. 17: 555-562.
9. BISHOP, A. E., J. M. POLAK, I. C. GREEN, M. G. BRYANT & S. R. BLOOM. 1980. The location of VIP in the pancreas of man and rat. Diabetologia 18: 73-78.
10. FAHRENKRUG, J., J. H. PEDERSON, Y. YAMASHITA, B. OTTESEN, T. HÖKFELT & J. M. LUNDBERG. 1987. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man. Regul. Pept. 18: 51-61.
11. HOLST, J. J., J. FAHRENKRUG, S. KNUHTSEN, S. L. JENSEN, O. V. NIELSON, J. M. LUNDBERG & T. HÖKFELT. 1987. VIP and PHI in the pig pancreas: Coexistence, corelease, and cooperative effects. Am. J. Physiol. 252: G182-G189.
12. ANTEUNIS, A., G. HEIBLUM, A. ASTESANO, J.-C. MARIE, D. H. B. HOA, M. KERGOAT, B. PORTHA & G. ROSSELIN. 1986. Evidence for the presence of VIP receptors in pancreatic B cells by quantitative electron microscopic autoradiography. C. R. Acad. Sci. Paris 303: 357-360.
13. INAGAKI, N., H. YOSHIDA, M. MIZUTA, N. MIZUNO, Y. FUJII, T. GONOI, J. MIYAZAKI & S. SEINO. 1994. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 91: 2679-2683.
14. KATO, I., Y. SUZUKI, A. AKABANE, H. YONEKURA, O. TANAKA, H. KONDO, S. TAKASAWA, T. YOSHIMOTO & H. OKAMOTO. 1994. Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic β cells. J. Biol. Chem. 269:21223-21228.
15. HANAHAN, D. 1985. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115-122.
16. SACCHI, T. B., D. BANI & G. BILIOTTI. 1992. Immunohistochemical and ultrastructural abnormalities of islet tissue in patients with VIP-producing tumors of the pancreas. Pancreas 7: 601-610.
17. WAHL, M. A., S. G. STRAUB & H. P. T. AMMON. 1993. Vasoactive intestinal polypeptide-augmented insulin release: Actions on ionic fluxes and electrical activity of mouse islets. Diabetologia 36: 920-925.
18. AHRÉN, B. & I. LUNDQUIST. 1981. Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse. Diabetologia 20: 54-59.
19. TAKASAWA, S., K. NATA, H. YONEKURA & H. OKAMOTO. 1993. Cyclic ADP-ribose in insulin secretion from pancreatic β cells. Science 259: 370-373.
20. TAKASAWA, S., A. TOHGO, N. NOGUCHI, T. KOGUMA, K. NATA, T. SUGIMOTO, H. YONEKURA & H. OKAMOTO. 1993. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol. Chem. 268: 26052-26054.
21. TOHGO, A., S. TAKASAWA, N. NOGUCHI, T. KOGUMA, K. NATA, T. SUGIMOTO, Y. FURUYA, H. YONEKURA & H. OKAMOTO. 1994. Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38. J. Biol. Chem. 269: 28555-28557.
22. OKAMOTO, H., S. TAKASAWA & A. TOHGO. 1995. New aspects of the physiological significance of NAD, poly ADP-ribose and cyclic ADP-ribose. Biochimie 77: 356-363.
23. ISHIHARA, T., R. SHIGEMOTO, K. MORI, K. TAKAHASHI & S. NAGATA. 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8: 811-819.
24. PFEIFER, M. A., J. B. HALTER & D. PORTE. 1981. Insulin secretion in diabetes mellitus. Am. J. Med. 70: 579-588.
25. STEFAN, Y., L. ORCI, F. MALAISSE-LAGAE, A. PERRELET, Y. PATEL & R. H. UNGER. 1982. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31: 694-700.
26. GEPTS, W. & P. M. LECOMPTE. 1985. The pathology of type I (Juvenile) diabetes. In The Diabetic Pancreas, B. W. Volk and E. R. Arguilla, Eds.: 337-365. Plenum Press. New York.
27. STRIBLING, R., E. BRUNETTE, D. LIGHT, K. GAENSLER & R. DEBS. 1992. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. U.S.A. 89: 11277-11281.
28. HYDE, S. C., D. R. GILL, C. F. HIGGINS, A. E. O. TREZISE, L. J. MACVINISH, A. W. CUTHBERT, R. RATCLIFF, M. J. EVANS & W. H. COLLEDGE. 1993. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362: 250-255.